Correlation Between Emergent Biosolutions and Genomma Lab

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Emergent Biosolutions and Genomma Lab at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Emergent Biosolutions and Genomma Lab into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Emergent Biosolutions and Genomma Lab Internacional, you can compare the effects of market volatilities on Emergent Biosolutions and Genomma Lab and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Emergent Biosolutions with a short position of Genomma Lab. Check out your portfolio center. Please also check ongoing floating volatility patterns of Emergent Biosolutions and Genomma Lab.

Diversification Opportunities for Emergent Biosolutions and Genomma Lab

0.48
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Emergent and Genomma is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Emergent Biosolutions and Genomma Lab Internacional in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genomma Lab Internacional and Emergent Biosolutions is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Emergent Biosolutions are associated (or correlated) with Genomma Lab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genomma Lab Internacional has no effect on the direction of Emergent Biosolutions i.e., Emergent Biosolutions and Genomma Lab go up and down completely randomly.

Pair Corralation between Emergent Biosolutions and Genomma Lab

Considering the 90-day investment horizon Emergent Biosolutions is expected to generate 2.91 times more return on investment than Genomma Lab. However, Emergent Biosolutions is 2.91 times more volatile than Genomma Lab Internacional. It trades about 0.11 of its potential returns per unit of risk. Genomma Lab Internacional is currently generating about 0.21 per unit of risk. If you would invest  906.00  in Emergent Biosolutions on September 1, 2024 and sell it today you would earn a total of  106.00  from holding Emergent Biosolutions or generate 11.7% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy95.45%
ValuesDaily Returns

Emergent Biosolutions  vs.  Genomma Lab Internacional

 Performance 
       Timeline  
Emergent Biosolutions 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Emergent Biosolutions are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental drivers, Emergent Biosolutions unveiled solid returns over the last few months and may actually be approaching a breakup point.
Genomma Lab Internacional 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Genomma Lab Internacional are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile essential indicators, Genomma Lab reported solid returns over the last few months and may actually be approaching a breakup point.

Emergent Biosolutions and Genomma Lab Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Emergent Biosolutions and Genomma Lab

The main advantage of trading using opposite Emergent Biosolutions and Genomma Lab positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Emergent Biosolutions position performs unexpectedly, Genomma Lab can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genomma Lab will offset losses from the drop in Genomma Lab's long position.
The idea behind Emergent Biosolutions and Genomma Lab Internacional pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Money Managers
Screen money managers from public funds and ETFs managed around the world
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators